Retinyl substituted-benzyl ethers. Inhibition of mammary carcinogenesis by retinyl 3,4,5-trimethoxybenzyl ether (RTMBE)

Anti-Cancer Drug Design

Volumn 13, Issue 3, 1998, Pages 159-182

  Shealy, Y Fulmer ^a   Frye, Jerry L ^a   Hill, Donald L ^a   Sani, Brahma P ^a   Rogers, Tina S ^a   Riordan, James M ^a   Krauth, Charles A ^a   Lin, Tsu Han ^a   Eto, Isao ^b   Grubbs, Clinton J ^b  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Chemoprevention; CRPB binding; Mammary cancer; Retinyl ethers; RTMBE

Indexed keywords

RETINOID; RETINOL; RETINOL ACETATE; RETINOL BINDING PROTEIN; RETINOL METHYL ETHER; RETINOL PALMITATE; RETINYL 2 PROPYNYL; RETINYL 3,4,5 TRIMETHOXYBENZYL ETHER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOGENESIS; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG TISSUE LEVEL; FEMALE; LIVER; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTICARCINOGENIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MASS SPECTROMETRY; MICE; MOLECULAR STRUCTURE; RATS; RATS, SPRAGUE-DAWLEY; SPECTROPHOTOMETRY, ULTRAVIOLET; TISSUE DISTRIBUTION; VITAMIN A;

ANIMALIA;

EID: 7144256226     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. GRUBBS, C J, MOON, R.C., SPORN, M.B. & NEWTON, D.L. (1977). Inhibition of mammary cancer by retinyl methyl ether. Cancer Research, 37, 599.
2. GRUBBS, C.J., STEELE, V.E., CASEBOLT, T, JULIANA, M.M , ETO, I., WHITAKER, L M., DRAGNEV, K H , KELLOFF, G. J. & LUBET, R.L. (1995). Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Research, 15, 709.
3. LIN, T.-H , ROGERS, TS., HILL, D.L., SIMPSON-HERREN, L.. FARNELL, D.R , KOCHHAR, D.M., MUZAFFAR, A., BROUILLETTE, W.J. & MUCCIO, D.D. (1996). Murine toxicology and pharmacology of UAB-8, a conformationally constrained analogy of retinoic acid. Toxicology and Applied Pharmacol- ogy, 139, 310.
4. LOTAN, R , NEUMANN, G. & LOTAN, D. (1980). Relationships among retinoid structure, inhibition of growth and cellular retinoic acid-binding protein in cultured S91 melanoma cells. Cancer Research, 40, 1097.
5. MCPHILLIPS, D.M., LINDAMOOD, C. III, HEATH, J.E & HILL, D.L. (1988). The disposition and toxicology of retinyl methyl ether in rats dosed orally. Drug Metabolism and Disposition, 16, 683.
6. NARINDRASORASAK, S. & LAKSHMANAN, M R. (1972). Conversion of retinyl methyl ether into retinol in the rat in vitro. Biochemistry, 11, 380.
7. NARINDRASORASAK, S., PIMPA, P. & LAKSHMANAN, M.R (1971). The metabolism of retinyl methyl ether in the rat in vivo. Biochemical Journal, 122, 427.
8. ROBESON, C.D., CAWLEY, J.D., WEISLER, L., STERN, M.H., EDDINGER, C.C. & CHECHAK, A.J. (1955). Chemistry of vitamin A. XXIV. The synthesis of geometric isomers of vitamin A via methyl β-methyl-glutaconate. Journal of the American Chemical Society, 77, 4111.
9. SANI, B.P. (1993). Binding affinities of retinoids to their binding proteins/receptors and their biological activities. In Retinoids. Progress in Research and Clinical Applications. Livera, M.A. & Packer, L. (eds), p. 237. Marcel Dekker: New York.
10. SANI, B.P. CONDON, S M & BANERJEE, C.K. (1980). Separation, purification and properties of retinoic acid-and retinol-binding proteins from a transplantable murine colon tumor. Biochimica et Biophysica Acta, 624, 226.
11. SANI, B.P , ZHANG, X.-K., HILL, D.L. & SHEALY, Y.F. (1996). Retinyl methyl ether: binding to transport proteins and effect on transcriptional regulation. Biochemical and Biophysical Research Communications, 223, 293.
12. SHANTZ, E.M , CAWLEY, J D, & EMBREE, N D (1943). Anhydro ('cyclized') vitamin A. Journal of the American Chemical Society, 65, 901.
13. SHEALY, Y.F. (1989). Synthesis and evaluation of some new retinoids for cancer chemoprevention. Preventive Medicine, 18, 624.
14. SHEALY, Y F., RIORDAN, J.M , FRYE, J L & CAMPBELL, S R (1996). Intramolecular Diels-Alder reactions of the retinoid side chain. Tetrahedron, 42, 405.
15. SHEALY, Y.F , FRYE, J L., RIORDAN, J M , HILL, D L , MCPHILLIPS, M , WILLE, J.J., SANI, B.P, KALIN, J R., ETO, I & GRUBBS, C.J (1997). Retinyl ethers as cancer chemopreventive agents. Suppression of mammary cancer. Anti-Cancer Drug Design, 12, 15.
16. SHIH, T W, SHEALY, Y F & HILL, D L (1991). Conversion of retinoid ethers to alcohols by enzymatic activity present in rat liver microsomes. Drug Metabolism and Disposition, 19, 336.
17. THOMPSON, J N. &. PITT, G.A J (1963). The conversion of retinyl methyl ether (vitamin A methyl ether) to retinol (vitamin A alcohol) in vivo. Biochimica et Biophysica Acta, 78, 753.
18. THOMPSON, H.J., GRUBBS, C J, BECCI, P J., SPORN, M B & MOON, R.C. (1978). Effect of retinoids on M-methyl-N-nitrosourea (MNU)-induced mammary cancer. Federation Proceedings, 37, 261.
19. VERMA, A.K. & BOUTWELL, R K (1977). Vitamin A acid (retinoid acid), a potent inhibitor of 12-O-tetradecanoylphorbol 13-acetate-induced ornithine decarboxylase activity in mouse epidermis. Cancer Research, 37, 2196.
20. VERMA, A.K., RICE, H.M., SHAPAS, B.G. & BOUTWELL, R.K. (1978). Inhibition of 12-O-tetradecanoylphorbol 13-acetate-induced ornithine decarboxylase activity in mouse epidermis by vitamin A analogs (retinoids). Cancer Research, 38, 793.
21. VERMA, A K , SHAPAS, B.G., RICE, H M & BOUTWELL, R.K. (1979). Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion. Cancer Research, 39, 319.